Organon (OGN) R&D In Process (2021 - 2025)
Historic R&D In Process for Organon (OGN) over the last 5 years, with Q1 2025 value amounting to $6.0 million.
- Organon's R&D In Process fell 6000.0% to $6.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year decrease of 9259.26%. This contributed to the annual value of $81.0 million for FY2024, which is 91250.0% up from last year.
- Organon's R&D In Process amounted to $6.0 million in Q1 2025, which was down 6000.0% from $51.0 million recorded in Q3 2024.
- Over the past 5 years, Organon's R&D In Process peaked at $97.0 million during Q2 2022, and registered a low of $6.0 million during Q1 2025.
- Moreover, its 5-year median value for R&D In Process was $15.0 million (2024), whereas its average is $34.0 million.
- Per our database at Business Quant, Organon's R&D In Process crashed by 6000.0% in 2022 and then soared by 8750.0% in 2024.
- Organon's R&D In Process (Quarter) stood at $79.0 million in 2021, then plummeted by 87.34% to $10.0 million in 2022, then dropped by 20.0% to $8.0 million in 2023, then surged by 537.5% to $51.0 million in 2024, then plummeted by 88.24% to $6.0 million in 2025.
- Its last three reported values are $6.0 million in Q1 2025, $51.0 million for Q3 2024, and $15.0 million during Q2 2024.